Arweave and Injective Remain in the Red as Investors Port to Milei Moneda Presale for Portfolio Growth

TLDR

• Injective (INJ) trades on weekly losses even with steps to bring innovative features. 
• Arweave (AR) slumps on the weekly charts; investors scout for other options.
• Deflationary Milei Moneda ($MEDA) attracts investors with DeFi prospects.

While some of the top altcoins spiked earlier in the year, Arweave (AR) and Injective (INJ) are yet to record many positives in 2024. Both tokens had their altcoin price spiking in February, but somehow, INJ and AR are still in the red. Well, it’s a race for profits, and Arweave and Injective are behind. Milei Moneda ($MEDA) is one of the best altcoins to buy, as the meme coin is setting a cryptocurrency ICO to remember.

Watch out for the $MEDA presale.

Economize Like Milei: Invest in $MEDA!

 

Arweave Can’t Keep the Price Pump Going For Much Longer

AR was flying sky-high in February, as Arweave hit an 18-month high while experiencing growth on the platform. Arweave is a decentralized storage platform where users can store, share, and retrieve their data files in any format. Arweave celebrated three billion transactions on its blockchain as AR developers launched another revolutionary project on the network.

The Arweave ecosystem will see a hyper-parallel computer take over operations on the blockchain. The computer allows transactions in parallel, increasing speed and offering temporary storage in the bargain. Already, Arweave is one of the top crypto coins in the file-sharing sector, and AR got even more traction in February.

Despite its brief price pump, AR corrected for most of March, eventually slipping into 21.5% losses in the last week of March. AR was one of the best DeFi crypto tokens in February, and the token is clearly struggling to keep the gains now; can Bitcoin’s halving revive Arweave?

 

Injective Fighting the Bears With Ecosystem Developments

Injective had a little surge earlier in the year, but the tides have turned on INJ. Investors are already out the door, seeking profits on other platforms that are tipped to boom during Bitcoin’s halving. Injective is reacting accordingly, too, but it might not be in the fastest ways possible.

The INJ token is getting some boost, and it’s no doubt because of the recent Ionic Upgrade. Injective has achieved a way to promote interoperability between its chains and other networks through Injective Bridge, and the Ionic Upgrade is an enhancement to that feature. With that, both users and traders will be able to trade and transfer INJ and Injective assets between chains and networks.

For now, all that upgrade has little to no effect on the INJ token’s price, as Injective is still trading at 12% losses on the weekly charts and 14% losses in the past 30 days. Even Coincodex reported that INJ is 21% below its prediction for April; maybe it’s time to move on from Injective investments.

And we know just the right token to move to.

 

Milei Moneda Set To Keep the Investors With Real-Life Utility

Milei Moneda is here to stay, and its protocol is one that will keep investors in profit for the long term. Unlike many meme coins that pump and dump shortly after their presale launches, $MEDA sports a fine mix of DeFi and meme features. That way, users stay entertained while they rake in profits.

Milei Moneda comes with deflationary features, encouraging users to invest long-term.  Meme coins like Dogecoin and Shiba Inu often have to burn some of their tokens to reduce the available supply, but Milei Moneda is two steps ahead there. Some 5% of its token supply is devoted to token burns to ensure that the $MEDA token value will rise as traders use it.

Milei Moneda is preparing smart contracts for its prospective DeFi projects. They are already in the audit phase, and that will set the pace for dApps on the $MEDA ecosystem. Milei Moneda is where an active community meets massive incentives. The members get trending NFTs, giveaways, and rewards for the best governance proposals as incentives for their activity on the platform.

You can hop on the Milei Moneda presale today and start your journey to profits in 2024. $MEDA tokens sell for $0.0125, and if you get them now, you will be in guaranteed profits when the launch takes the price to $0.020 by mid-year. And that’s only the start.

Got $MEDA curiosity? Visit us or chat on Telegram for the inside scoop. Fast, fun, and informative!

The post Arweave and Injective Remain in the Red as Investors Port to Milei Moneda Presale for Portfolio Growth appeared first on BitcoinWorld.